High-density-lipoprotein-independent killing of Trypanosoma brucei by human serum.

[1]  S. Hajduk,et al.  Endocytosis of a cytotoxic human high density lipoprotein results in disruption of acidic intracellular vesicles and subsequent killing of African trypanosomes , 1994, The Journal of cell biology.

[2]  A. Tait,et al.  Epidemiological relationships of Trypanosoma brucei stocks from South East Uganda: evidence for different population structures in human infective and non-human infective isolates , 1994, Parasitology.

[3]  Diana J L Williams,et al.  African Buffalo Serum Contains Novel Trypanocidal Protein , 1994, The Journal of eukaryotic microbiology.

[4]  J. S. Owen,et al.  Heterogeneity in the properties of the trypanolytic factor in normal human serum. , 1994, Molecular and biochemical parasitology.

[5]  K. Gomi,et al.  Elevated complement activities of sera from patients with high density lipoprotein deficiency (Tangier disease): the presence of normal level of clusterin and the possible implication in the atherosclerosis , 1993, Clinical and experimental immunology.

[6]  T. Tobe,et al.  The role of HDL consisting of SP-40,40, apo A-I, and lipids in the formation of SMAC of complement. , 1993, Journal of biochemistry.

[7]  T. Hughes,et al.  Transgenic mice expressing human apolipoprotein A-I have sera with modest trypanolytic activity in vitro but remain susceptible to infection by Trypanosoma brucei brucei. , 1992, Journal of lipid research.

[8]  Y. Takahashi,et al.  Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J). , 1992, Journal of biochemistry.

[9]  M. Gillett,et al.  Comparison of the cytolytic effects in vitro on Trypanosoma brucei brucei of plasma, high density lipoproteins, and apolipoprotein A-I from hosts both susceptible (cattle and sheep) and resistant (human and baboon) to infection. , 1992, Journal of lipid research.

[10]  M. Gillett,et al.  Trypanosoma brucei brucei: differences in the trypanocidal activity of human plasma and its relationship to the level of high density lipoproteins. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[11]  M. Wilson,et al.  Clusterin enhances the formation of insoluble immune complexes. , 1991, Biochemical and biophysical research communications.

[12]  M. Peitsch,et al.  Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. , 1991, The Journal of biological chemistry.

[13]  M. Rifkin.  Role of phospholipids in the cytotoxic action of high density lipoprotein on trypanosomes. , 1991, Journal of lipid research.

[14]  M. Rifkin.  Trypanosoma brucei: cytotoxicity of host high-density lipoprotein is not mediated by apolipoprotein A-I. , 1991, Experimental parasitology.

[15]  M. Loomis,et al.  A survey for a trypanocidal factor in primate sera. , 1990, The Journal of protozoology.

[16]  J. Seed,et al.  Nature of the trypanocidal factor in human serum. , 1989, The Journal of parasitology.

[17]  S. Hajduk,et al.  Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein. , 1989, The Journal of biological chemistry.

[18]  S. Yokoyama,et al.  A Japanese family with high density lipoprotein deficiency. , 1983, Atherosclerosis.

[19]  K. Esser,et al.  Isolation and characterization of a new serodeme of Trypanosoma rhodesiense. , 1979, The American journal of tropical medicine and hygiene.

[20]  M. Rifkin.  Trypanosoma brucei: some properties of the cytotoxic reaction induced by normal human serum. , 1978, Experimental parasitology.

[21]  M. Rifkin.  Identification of the trypanocidal factor in normal human serum: high density lipoprotein. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Godfrey,et al.  Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. , 1970, Experimental parasitology.

[23]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[24]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[25]  S. Hajduk,et al.  Reconstitution of the trypanolytic factor from components of a subspecies of human high-density lipoproteins. , 1995, Molecular and biochemical parasitology.

[26]  P. Barth.  A new method for the isolation of the trypanocidal factor from normal human serum. , 1989, Acta tropica.

[27]  M. Rifkin.  Interaction of high‐density lipoprotein with Trypanosoma brucei: Effect of membrane stabilizers , 1983, Journal of cellular biochemistry.

[28]  P. K. Murray,et al.  Treatment with suramin and 2-substituted 5-nitroimidazoles of chronic murine Trypanosoma brucei infections with central nervous system involvement. , 1983, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[29]  F. Hawking.  The resistance to human plasma of Trypanosoma brucei, T. rhodesiense and T. gambiense. I. Analysis of the composition of trypanosome strains. , 1976, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  F. Hawking.  The resistance to human plasma of Trypanosoma brucei, T. rhodesiense and T. gambiense. II. Survey of strains from East Africa and Nigeria. , 1976, Transactions of the Royal Society of Tropical Medicine and Hygiene.